Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Oct 1, 2008 goldstein joseph l Director Sell 500 22.32
May 14, 2010 goldstein joseph l Director Disposition (Non Open Market) 4,600 27.63
May 14, 2010 goldstein joseph l Director Option Execute 5,000 25.43
May 17, 2010 goldstein joseph l Director Sell 400 28.06
May 21, 2014 poon christine a Director Buy 255 291.90
Nov 25, 2014 poon christine a Director Buy 400 410.00
Jun 14, 2010 ryan arthur f Director Buy 10,000 26.98
Sep 14, 2011 ryan arthur f Director Disposition (Non Open Market) 32,145 64.85
Sep 14, 2011 ryan arthur f Director Option Execute 115,000 9.17 - 24.41
Jan 12, 2012 ryan arthur f Director Sell 25,500 78.86 - 79.09
May 10, 2012 ryan arthur f Director Disposition (Non Open Market) 7,000 n/a
Aug 10, 2012 ryan arthur f Director Sell 10,000 136.15
Nov 1, 2012 ryan arthur f Director Sell 10,000 145.57
May 23, 2013 ryan arthur f Director Disposition (Non Open Market) 3,000 n/a
May 31, 2013 ryan arthur f Director Sell 2,500 249.45 - 249.58
Aug 22, 2013 ryan arthur f Director Disposition (Non Open Market) 4,042 236.64
Aug 23, 2013 ryan arthur f Director Sell 10,958 238.47
Aug 22, 2013 ryan arthur f Director Option Execute 30,000 18.61 - 57.11
Oct 2, 2007 shooter eric m Director Sell 10,000 18.30 - 18.37
Oct 2, 2007 shooter eric m Director Option Execute 10,000 7.66
Showing 241-260 of 868 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)